Study examines aspirin dose, fibrin network permeability in diabetes

12/18/2011 | PhysiciansBriefing.com

Type 1 diabetes patients who received 320 mg of aspirin for four weeks attained better fibrin network permeability, compared with those who took 75 mg of aspirin for the same period, a study Diabetes Care revealed. "The observed lack of effect with low-dose aspirin may contribute to aspirin treatment failure in diabetes," the authors wrote.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC